Cargando…
(1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis
OBJECTIVE: To investigate the metabolomic profiles of patients with multiple sclerosis (MS) and to define the metabolic pathways potentially related to MS pathogenesis. METHODS: Plasma samples from 73 patients with MS (therapy-free for at least 90 days) and 88 healthy controls (HC) were analyzed by...
Autores principales: | Cocco, Eleonora, Murgia, Federica, Lorefice, Lorena, Barberini, Luigi, Poddighe, Simone, Frau, Jessica, Fenu, Giuseppe, Coghe, Giancarlo, Murru, Maria Rita, Murru, Raffaele, Del Carratore, Francesco, Atzori, Luigi, Marrosu, Maria Giovanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694073/ https://www.ncbi.nlm.nih.gov/pubmed/26740964 http://dx.doi.org/10.1212/NXI.0000000000000185 |
Ejemplares similares
-
Multi-Platform Characterization of Cerebrospinal Fluid and Serum Metabolome of Patients Affected by Relapsing–Remitting and Primary Progressive Multiple Sclerosis
por: Murgia, Federica, et al.
Publicado: (2020) -
Interaction between HLA-DRB1-DQB1 Haplotypes in Sardinian Multiple Sclerosis Population
por: Cocco, Eleonora, et al.
Publicado: (2013) -
Metabolomic Changes in Patients Affected by Multiple Sclerosis and Treated with Fingolimod
por: Murgia, Federica, et al.
Publicado: (2023) -
Menopausal transition in multiple sclerosis: relationship with disease activity and brain volume measurements
por: Lorefice, Lorena, et al.
Publicado: (2023) -
New horizons for multiple sclerosis therapeutics: milestones in the development of ocrelizumab
por: Frau, Jessica, et al.
Publicado: (2018)